An HHS spokesperson said Dr. Jay Bhattacharya had concerns about the paper’s methodology. Some current or former CDC ...
The acting director of the Centers for Disease Control and Prevention has delayed publication of a CDC report showing the ...
Morning Overview on MSN
Once-controversial exon-skipping drugs return as hope for Duchenne
Exon-skipping therapies for Duchenne muscular dystrophy, a class of drugs that triggered fierce regulatory debate when they ...
While recent FDA guidance speaks to the agency’s support of innovative trial designs—including the use of external ...
BACKGROUND: Medically tailored meals (MTM) have unanswered implementation questions. Providing MTM for a specific individual, ...
Abstract: In this article, we revisit a communication control co-design problem for a class of two-player stochas tic differential games on an infinite horizon. Each ‘player’ represents two active ...
Theriva Biologics has received FDA agreement on the core design elements of a pivotal phase 3 trial evaluating zabilugene ...
Abstract: Safety and data efficiency are important concerns in data-driven control, especially for nonlinear systems with unknown dynamics and subject to disturbances. In this work, we consider a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results